Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
31.9M
-
Shares change
-
+2.04M
-
Total reported value, excl. options
-
$535M
-
Value change
-
+$35.7M
-
Put/Call ratio
-
3.43
-
Number of buys
-
53
-
Number of sells
-
-28
-
Price
-
$16.79
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2017
91 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q4 2017.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.9M shares
.
Largest 10 shareholders include NEA Management Company, LLC (8.58M shares), WELLINGTON MANAGEMENT GROUP LLP (3.58M shares), FMR LLC (2.84M shares), Redmile Group, LLC (1.93M shares), FRANKLIN RESOURCES INC (1.93M shares), JENNISON ASSOCIATES LLC (1.59M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.26M shares), Vanguard Group Inc (1.03M shares), BlackRock Inc. (992K shares), and JANUS HENDERSON GROUP PLC (978K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.